You are here

Article info

Article menu
Multiple sclerosis
Research paper
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Free

Authors

  1. Correspondence to Dr Orla Tuohy, Department of Clinical Neurosciences, University of Cambridge, Box 165, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; oct21{at}cam.ac.uk
View Full Text

Citation

Tuohy O, Costelloe L, Hill-Cawthorne G, et al
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:208-215.

Publication history

  • Received January 24, 2014
  • Revised April 4, 2014
  • Accepted May 1, 2014
  • First published May 21, 2014.
Online issue publication 
January 14, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions